Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public-private hospital partnership during the 2022 NYC mpox outbreak
- PMID: 37502253
- PMCID: PMC10369430
- DOI: 10.1017/ash.2023.194
Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public-private hospital partnership during the 2022 NYC mpox outbreak
Abstract
During the 2022 mpox outbreak, tecovirimat was accessed through an expanded access investigational new drug (EA-IND) protocol. We leveraged a unique public/private hospital partnership in New York City to create a novel infrastructure to navigate the EA-IND's regulatory requirements and rapidly provide tecovirimat to patients.
© The Author(s) 2023.
Conflict of interest statement
All authors report no conflicts of interest relevant to this article.
Figures
References
-
- United States Centers for Disease Control and Prevention. Mpox. 2022 U.S. Map and Case Count. https://www.cdc.gov/poxvirus/mpox/response/2022/us-map.html. Accessed March 13, 2023.
-
- New York City Department of Health. Mpox 2022 Summary: Cases. https://www.nyc.gov/assets/doh/downloads/pdf/monkeypox/mpox-response-dat.... Accessed March 13, 2023.
-
- United States Centers for Disease Control and Prevention. October 24, 2022. Expanded Access IND Protocol: Use of Tecovirimat (TPOXX®) for Treatment of Human Non-Variola Orthopoxvirus Infections in Adults and Children IND No. 116,039, CDC IRB No. 6402, Version 6.2. https://www.cdc.gov/poxvirus/mpox/pdf/Tecovirimat-IND-Protocol-CDC-IRB.pdf. Accessed March 13, 2023.
-
- United States Department of Health and Human Services. Administration for Strategic Preparedness and Response. ASPR Awards $21 Million to Health Facilities to Enhance Nation’s Preparedness for Special Pathogens. October 24, 2022. https://aspr.hhs.gov/newsroom/Pages/RESPTC-Prep-Award-24Oct2022.aspx. Accessed March 27, 2023.
-
- Mgbako O, Ditullio D, PaganPirallo P, et al. Outcomes of a telehealth visit model to deliver tecovirimat. Conference on Retroviruses and Opportunistic Infections. Abstract 1102. Seattle, Washington. February 2023.
Publication types
LinkOut - more resources
Full Text Sources